RUA Life Sciences (AIM:RUA), the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM), will be conducting an Investor Presentation covering their interim results for the period ended 30th September 2022.
The event will take place at 11.00am on Monday 12th December with Bill Brown (Chairman) and Caroline Stretton (CEO) presenting from the company.
The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.
